CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by CollPlant Holdings Ltd. (also referred to as CollPlant Biotechnologies Ltd.) for the month of July 2018, with a specific filing date of July 5, 2018. The registrant is a foreign private issuer based in Ness Ziona, Israel, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a corporate governance event and does not contain financial statements or performance data.
Material Changes
The material change disclosed in this filing is the appointment of Dr. Wolfgang Ruttenstorfer to the Company's Board of Directors, as detailed in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items beyond the board appointment.
Key Facts for Investor Verification
- Dr. Wolfgang Ruttenstorfer has been appointed to the Board of Directors.
- The appointment was announced via a press release dated July 5, 2018.
- The filing contains no financial performance data for the period.
- The report was signed by Eran Rotem, Deputy CEO and Chief Financial Officer.